Co-Diagnostics announces $3.8M registered direct offering of 9.62M shares at $0.40/share

Co-Diagnostics, Inc.

Sold 9,619,000 common shares at $0.40/share in registered direct offering to institutional investors.
Gross proceeds $3.8M; net after 7% placement agent fee and expenses; use for working capital.
Maxim Group LLC is sole placement agent; closing expected Sept 18, 2025.
Investors get participation rights in up to 30% of future financings within 12 months.
Offering priced at-the-market under Nasdaq rules; customary 30-day lock-up on new issuances.

item 1.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.